Back to mobile site

Amylin Pharma (AMLN), Eli Lilly (LLY), and Alkermes (ALKS) Announce Results of DURATION-4 for BYDUREON

June 15, 2010 8:27 AM EDT Send to a Friend
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced results from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login